← Open Payments lookup

COURTNAY KINCAID: Open Payments

NPI 1740765023 · POCAHONTAS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$221 in 12 payments from 8 companies in 2025. Trend: 2023 $403 · 2024 $358 · 2025 $221

Food & beverage: $221
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$66
ABBVIE INC.1$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$30
Axsome Therapeutics, Inc.1$28
Sumitomo Pharma America, Inc.1$17
Phathom Pharmaceuticals, Inc.2$17
Novo Nordisk Inc1$17
GlaxoSmithKline, LLC.1$14

Products named: FARXIGA, UBRELVY, CAPLYTA, Auvelity, GEMTESA, VOQUEZNA, Ozempic, AIRSUPRA.

Industry payments across AR — which companies pay providers there.